Rybelsus 14 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FV5XZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,451
Award facts
- Contract value 100% obligated
- $32,451.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Rybelsus 14 mg tablets (30-count units) valued at $32,451.14. This competitively awarded, firm fixed-price delivery order represents a direct procurement with an ultimate completion date of October 31, 2025. The contract carries no set-aside designation, indicating it was competed among all eligible vendors. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location at the same address.
This delivery order is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including support for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen Drug Corp's consistent success in securing federal pharmaceutical contracts demonstrates its capacity to meet stringent federal procurement requirements and supply critical medications across multiple therapeutic domains to the defense medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FV5XZ?
SPE2DB26FV5XZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FV5XZ worth?
The government has obligated $32,451 on SPE2DB26FV5XZ.
Is contract SPE2DB26FV5XZ an order under another contract?
Yes. SPE2DB26FV5XZ is a delivery order under SPE2DB22D2006, an indefinite delivery contract.
Was contract SPE2DB26FV5XZ competed?
The extent of competition for SPE2DB26FV5XZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award